drugset / Trial / NCT02400320

Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol

NCT02400320

Phase 4 Withdrawn GlaxoSmithKline
RandomizedParallel-groupSingle-blindOther

Summary

The purpose of this study is to determine local skin safety of a topical analgesic spray containing a combination of diclofenac, methyl salicylate, menthol and compare it with a topical analgesic gel containing a combination of diclofenac, methyl salicylate, and menthol.

Timeline

Start
2016-03-01
Primary completion
2016-06-01
Completion
2016-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Flaxseed oil Unknown 3 % Topical
Background Diclofenac Other / unclassified 1.16 % Topical
Background Menthol Small molecule 5 % Topical
Background Methyl Salicylate Small molecule 10 % Topical

Indications